Diffuse cutaneous mucinoses.
Jackson EM, English JC 3rd.
Dermatol Clin. 2002 Jul;20(3):493-501. doi: 10.1016/s0733-8635(02)00017-7.
[Pretibial myxedema: pathogenetic features and clinical aspects].
Sabanova EA, Fadeyev VV, Potekaev NN, Lvov AN.
Probl Endokrinol (Mosk). 2019 Jun 30;65(2):134-138. doi: 10.14341/probl9848.
Pretibial Myxedema: Case Presentation and Review of Treatment Options.
Kim WB, Mistry N, Alavi A, Sibbald C, Sibbald RG.
Int J Low Extrem Wounds. 2014 Jun;13(2):152-154. doi: 10.1177/1534734614531485. Epub 2014 May 7.
Pretibial myxedema and high-dose intravenous immunoglobulin treatment.
Antonelli A, Navarranne A, Palla R, Alberti B, Saracino A, Mestre C, Roger P, Agostini S, Baschieri L.
Thyroid. 1994 Winter;4(4):399-408. doi: 10.1089/thy.1994.4.399.
Euthyroid pretibial myxedema.
Chen JJ, Ladenson PW.
Am J Med. 1987 Feb;82(2):318-20. doi: 10.1016/0002-9343(87)90077-5.
Thyroid and the eye.
Chavis PS.
Curr Opin Ophthalmol. 2002 Dec;13(6):352-6. doi: 10.1097/00055735-200212000-00002.
Treatment of pretibial myxedema with dexamethazone injected subcutaneously by mesotherapy needles.
Vannucchi G, Campi I, Covelli D, Forzenigo L, Beck-Peccoz P, Salvi M.
Thyroid. 2013 May;23(5):626-32. doi: 10.1089/thy.2012.0429.
Hyperthyroidism.
Sendrowski DP.
Optom Clin. 1994;3(4):87-97.
Observing pretibial myxedema in patients with Graves' disease using digital infrared thermal imaging and high-resolution ultrasonography: for better records, early detection, and further investigation.
Shih SR, Lin MS, Li HY, Yang HY, Hsiao YL, Chang MT, Chen CM, Chang TC.
Eur J Endocrinol. 2011 Apr;164(4):605-11. doi: 10.1530/EJE-10-1095. Epub 2011 Jan 25.
Pretibial myxedema without ophthalmopathy: an initial presentation of Graves' disease.
Lohiya S, Lohiya V, Stahl EJ.
Am J Med Sci. 2013 Jul;346(1):73-5. doi: 10.1097/MAJ.0b013e318288a6fa.
